Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis

  • The original article was published in Experimental Hematology & Oncology 2014 3:10

After the publication of this work [1], it was brought to our attention that a statement in the article is not consistent with the data. The statement “Prior RBC transfusions were found to significantly increase the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization” is not a correct reflection of the results from the data analysis in Table 2 of the article.

The corrected statement is provided here as follows:

“Prior RBC transfusions were found to significantly shorten the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization.”

References

  1. 1.

    Smith DB, Beach CL, Mahmoud D, Weber L, Henk HJ: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 2014, 3: 10. 10.1186/2162-3619-3-10

    PubMed Central  PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Henry J Henk.

Additional information

B Douglas Smith, Dalia Mahmoud and Henry J Henk contributed equally to this work.

The online version of the original article can be found at 10.1186/2162-3619-3-10

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Smith, B.D., Beach, C.L., Mahmoud, D. et al. Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 3, 19 (2014). https://doi.org/10.1186/2162-3619-3-19

Download citation